Thrombotic microangiopathy in children: Redefining hemolytic uremic syndrome, thrombotic thrombocytopenic purpura and related disorders

Bibliographic Details
Title: Thrombotic microangiopathy in children: Redefining hemolytic uremic syndrome, thrombotic thrombocytopenic purpura and related disorders
Authors: Mamta Manglani, Pranoti Kini
Source: Pediatric Hematology Oncology Journal, Vol 9, Iss 1, Pp 45-53 (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Pediatrics
Subject Terms: Thrombotic microangiopathy (TMA), Hemolytic uremic syndrome (HUS), Thrombotic thrombocytopenia purpura (TTP), ADAMTS13, Upshaw schulman syndrome (USS), Pediatrics, RJ1-570
More Details: Thrombotic microangiopathy (TMA) is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and end-organ ischemic damage. The primary mechanism involved is the occurrence of microthrombi due to deficient activity of ADAMTS13 (A Disintegrin And Metalloprotease with ThromboSpondin type 1 repeats, member 13). The most common types of TMA in children are Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome (STEC-HUS) followed by complement-mediated (CM) TMA, Streptococcus pneumoniae-associated hemolytic uremic syndrome (Sp-HUS) and hereditary thrombotic thrombocytopenic purpura (hTTP) and other rare causes. Since the outcomes are dismal if appropriate treatment is not promptly initiated, there is a need to have a high clinical suspicion. Additionally, urgently performing ADAMTS13 functional activity and autoantibody levels can help differentiate hTTP, immune thrombotic thrombocytopenic purpura (iTTP), and CM-TMA. The etiological differentiation is crucial as eculizumab is a specific therapy with exceedingly good results in CM-TMA. While plasma exchanges are required for iTTP, besides corticosteroids and/or rituximab, plasma infusions suffice for hTTP. This review focuses on the commonly encountered congenital and acquired types of TMA in children and their varied presentations while briefly touching upon the rarer disorders causing TMA.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2468-1245
Relation: http://www.sciencedirect.com/science/article/pii/S2468124524000056; https://doaj.org/toc/2468-1245
DOI: 10.1016/j.phoj.2024.01.005
Access URL: https://doaj.org/article/60a9745ee91747b2829473ab503950ae
Accession Number: edsdoj.60a9745ee91747b2829473ab503950ae
Database: Directory of Open Access Journals
More Details
ISSN:24681245
DOI:10.1016/j.phoj.2024.01.005
Published in:Pediatric Hematology Oncology Journal
Language:English